RVTY — Revvity Inc. stock price and chart

RVTY

Revvity Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.02% · Russell 1000 0.02% · US Stock Market 0.02% · Russell 3000 0.02%

$143.45-2.24%

as of market close, Sep 18, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

60.080.0100.0120.0140.0160.0180.0010.0M$143.45

2026-09-18

Price$143.45

MA20$108.86

MA50$100.27

Vol13.2M

What would $1,000 invested in RVTY be worth today? →

RVTY returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $143.45
Change YTD: +48.27%
Next earnings: Oct 26, 2026
Market cap: 16B2016-09 6.1B2026-09 16B+160.8% over the window
Enterprise value: 18.4B
Shares outstanding: 111.6M2016-07 109.4M2026-07 111.6M+2.0% over the window
52W low: $81.22
52W high: $149.52
From 52W high: -4.06%
From 52W low: +76.62%
52W range: 91%
Beta: 1.07

Volume

Rel volume: 1.89×
30D volume: 1.8M
30D $ vol: 227.2M

Fundamentals

Sales (ttm): 2.9B2016-07 2B2026-07 2.9B+42.2% over the window
Sales/share: $26.092016-07 $18.722026-07 $26.09+39.4% over the window
EPS (ttm): $2.102016-07 $2.102026-07 $2.10+0.1% over the window
FCF (ttm): 558.1M2016-07 280.3M2026-07 558.1M+99.1% over the window
FCF/share: $5.002016-07 $2.562026-07 $5.00+95.2% over the window
Book value/share: $64.782016-07 $19.092026-07 $64.78+239.4% over the window
Net margin: 8.16%2016-07 11.4%2026-07 8.2%-28.7% over the window
ROE: 3.29%2016-07 11.2%2026-07 3.3%-70.7% over the window
ROA: 1.97%2016-07 5.6%2026-07 2.0%-64.7% over the window
Debt / equity: 0.36×2016-07 0.512026-07 0.36-28.0% over the window
Current ratio: 1.802016-07 1.922026-07 1.80-6.4% over the window

Growth (CAGR, ttm) · 10Y

Sales: +3.99%2025-06-29 → 2026-07-052.8B → 2.9B (+4.1% total)+0.87%2023-07-02 → 2026-07-052.8B → 2.9B (+2.6% total)-4.86%2021-07-04 → 2026-07-053.7B → 2.9B (-22.0% total)+3.58%2016-07-03 → 2026-07-052B → 2.9B (+42.2% total)
Net income: -16.47%2025-06-29 → 2026-07-05285.2M → 237.6M (-16.7% total)-33.70%2023-07-02 → 2026-07-05818M → 237.6M (-71.0% total)-27.45%2021-07-04 → 2026-07-051.2B → 237.6M (-79.9% total)+0.13%2016-07-03 → 2026-07-05234.4M → 237.6M (+1.3% total)
FCF: +10.79%2025-06-29 → 2026-07-05503M → 558.1M (+11.0% total)+53.67%2023-07-02 → 2026-07-05153.2M → 558.1M (+264.3% total)-16.72%2021-07-04 → 2026-07-051.4B → 558.1M (-60.0% total)+7.13%2016-07-03 → 2026-07-05280.3M → 558.1M (+99.1% total)
Shares: -3.81%2025-06-29 → 2026-07-05116.1M → 111.6M (-3.9% total)-3.48%2023-07-02 → 2026-07-05124.1M → 111.6M (-10.1% total)-0.09%2021-07-04 → 2026-07-05112.1M → 111.6M (-0.5% total)+0.20%2016-07-03 → 2026-07-05109.4M → 111.6M (+2.0% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: -11.03%2025-06-29 → 2026-07-05$2.37 → $2.10 (-11.2% total)-31.15%2023-07-02 → 2026-07-05$6.46 → $2.10 (-67.5% total)-27.52%2021-07-04 → 2026-07-05$10.51 → $2.10 (-80.0% total)+0.01%2016-07-03 → 2026-07-05$2.10 → $2.10 (+0.1% total)
Sales/share: +8.10%2025-06-29 → 2026-07-05$24.11 → $26.09 (+8.2% total)+4.51%2023-07-02 → 2026-07-05$22.85 → $26.09 (+14.2% total)-4.77%2021-07-04 → 2026-07-05$33.32 → $26.09 (-21.7% total)+3.37%2016-07-03 → 2026-07-05$18.72 → $26.09 (+39.4% total)
FCF/share: +15.17%2025-06-29 → 2026-07-05$4.33 → $5.00 (+15.4% total)+59.21%2023-07-02 → 2026-07-05$1.23 → $5.00 (+305.3% total)-16.64%2021-07-04 → 2026-07-05$12.43 → $5.00 (-59.8% total)+6.92%2016-07-03 → 2026-07-05$2.56 → $5.00 (+95.2% total)
Book value/share: -0.48%2025-06-29 → 2026-07-05$65.10 → $64.78 (-0.5% total)+0.72%2023-07-02 → 2026-07-05$63.40 → $64.78 (+2.2% total)+11.36%2021-07-04 → 2026-07-05$37.82 → $64.78 (+71.3% total)+12.99%2016-07-03 → 2026-07-05$19.09 → $64.78 (+239.4% total)
Dividend/share: +0.00%2025-06-29 → 2026-07-05$0.28 → $0.28 (+0.0% total)+0.00%2023-07-02 → 2026-07-05$0.28 → $0.28 (+0.0% total)+0.00%2021-07-04 → 2026-07-05$0.28 → $0.28 (+0.0% total)+0.00%2016-07-03 → 2026-07-05$0.28 → $0.28 (+0.0% total)
Price: +63.51%2025-09-18 → 2026-09-18$87.76 → $143.45 (+63.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+8.76%2023-09-18 → 2026-09-18$111.49 → $143.45 (+28.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-5.22%2021-09-17 → 2026-09-18$187.56 → $143.45 (-23.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.40%2016-09-16 → 2026-09-18$53.32 → $143.45 (+169.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +63.96%2025-09-18 → 2026-09-18$87.52 → $143.45 (+63.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.06%2023-09-18 → 2026-09-18$110.59 → $143.45 (+29.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-4.99%2021-09-17 → 2026-09-18$185.33 → $143.45 (-22.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+10.72%2016-09-16 → 2026-09-18$51.81 → $143.45 (+176.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 68.3×2016-09 26.182026-09 67.38+157.3% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 44.6×2016-09 22.612026-09 44.61+97.3% over the window
Fwd P/E: 24.9×
P/S (ttm)Market cap ÷ TTM revenue.: 5.5×2016-09 3.002026-09 5.50+83.4% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.2×2016-09 2.942026-09 2.21-24.7% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 28.7×2016-09 21.902026-09 28.68+30.9% over the window
EV/EBITDA (fy): 23.8×
EV/Sales (ttm): 6.3×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.49%2016-07 4.6%2026-07 4.5%-0.7% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 0.20%
Dividend/share (fwd): $0.28
Buyback yield (realized, 1y)1 − shares_at(2026-07-05) ÷ shares_at(2025-06-29) = 1 − 111.6M ÷ 116.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 3.81%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (3.81%) + dividends paid over that year ($31.7M) ÷ market_cap_at(2025-06-29) ($11.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 4.08%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($475.8M) ÷ today's market cap ($16B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 2.97%2016-07 3.6%2026-07 3.9%+6.1% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $475.8M + TTM dividends $31.7M) ÷ today's market cap ($16B). Same caveat as the cash buyback yield.: 3.17%2016-07 4.2%2026-07 4.1%-0.7% over the window

Vs own 10Y history

P/E: 91st
P/OI: 92nd
P/S: 90th
P/B: 36th
P/FCF: 58th

Bar = where today’s multiple sits in RVTY’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-18

-2.24%

+15.40%

+26.11%

+43.45%

YTD

+48.27%

+63.46%

-23.52%

Financial statements

Open full RVTY financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-5.94%	+0.04%
JNJ	Johnson & Johnson	-0.41%	-0.09%
ABBV	AbbVie Inc.	+1.95%	-0.02%
MRK	Merck & Co. Inc.	+8.66%	-0.19%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.32%	+0.45%
TMO	Thermo Fisher Scientific Inc.	+10.60%	-1.04%
AMGN	Amgen Inc.	-9.32%	+1.55%
GILD	Gilead Sciences Inc.	+4.65%	-0.52%

Revvity Inc. (RVTY) trades at $143.45 with a live price and an interactive chart covering 53+ years of daily price history, plus key valuation metrics. ChartRow also publishes RVTY’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full RVTY financial statements →

RVTY — Revvity Inc. price, chart and key statistics